Asthma
Conditions
Keywords
Asthma, Anxiety, Stress
Brief summary
This is a study to investigate acceptability and feasibility of a novel protocol on exposure-based CBT for asthma-related fear delivered over the Internet (Internet-CBT).
Detailed description
Asthma is one of the most common chronic diseases around the world, with a high prevalence of anxiety disorders. In a prior study (ClinicalTrials.gov ID: NCT03158194) a protocol for exposure-based CBT was developed for asthma-related anxiety. The aim of the current study is to evaluate acceptability and feasibility of our protocol for asthma-related fear when delivered over the Internet (Internet-CBT). The plan is to include 30 participants that will all receive the intervention in this uncontrolled feasibility study.
Interventions
BEHAVIORALInternet-CBT for anxiety-related asthma
The specific assignments in the intervention will be based on individual behavior analysis for each participant.
Sponsors
Karolinska Institutet
Study design
Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE
Intervention model description
This is an uncontrolled feasibility study with one arm.
Eligibility
Sex/Gender
ALL
Age
18 Years to 75 Years
Healthy volunteers
No
Inclusion criteria
* asthma diagnosed by a physician * anxiety or stress related to asthma
Exclusion criteria
* severe psychiatric disorder * chronic obstructive pulmonary disease (COPD) and other chronic airway disorders other than asthma
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Catastrophizing about asthma Scale | Baseline to 8 weeks; baseline to 16 weeks; baseline to 24 weeks. | Change in catastrophizing cognitions about asthma measured with a self-rating scale at baseline, 8 weeks, 16 weeks and 24 weeks for analysis of effect. |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Asthma control test | Baseline to 8 weeks; baseline to 16 weeks; baseline to 24 weeks. | Change in asthma control measured with a self-rating scale at baseline, 8 weeks, 16 weeks and 24 weeks for analysis of effect. |
| Penn State Worry Questionnaire | Baseline to 8 weeks; baseline to 16 weeks; baseline to 24 weeks. | Change in subjective worry measured with a self-rating scale measured with a self-rating scale at baseline, 8 weeks, 16 weeks and 24 weeks for analysis of effect. |
| Asthma Quality of Life Questionnaire | Baseline to 8 weeks; baseline to 16 weeks; baseline to 24 weeks. | Change in asthma-related quality of life measured with a self-rating scale at baseline, 8 weeks, 16 weeks and 24 weeks for analysis of effect. |
| Short Health Anxiety Inventory (SHAI) | Baseline to 8 weeks; baseline to 16 weeks; baseline to 24 weeks. | Change in health anxiety measured with a self-rating scale at baseline, 8 weeks, 16 weeks and 24 weeks for analysis of effect. |
| Perceived Stress Scale | Baseline to 8 weeks; baseline to 16 weeks; baseline to 24 weeks. | Change in perceived stress measured with a self-rating scale at baseline, 8 weeks, 16 weeks and 24 weeks for analysis of effect. |
Countries
Sweden
Outcome results
None listed